GRI Bio, Inc. (GRI) Stock

About GRI Bio, Inc.

GRI Bio, Inc. is led by CEO W. Marc Hertz, employs 3 people, headquartered in US, publicly traded since 2023.

GRI Bio, Inc. (GRI) stock trades at $1.45 with a market capitalization of $3.17M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.04, reflecting a net loss over the last twelve months, price-to-book of 0.34, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.36 and $64.12, and currently trades 97.7% below its 52-week high.

On profitability, GRI Bio, Inc. generates a return on equity (ROE) of -134.03% (negative, reflecting a net loss), return on capital employed of -94.16%.

GRI Bio, Inc. by the numbers, 2018–2025

Between 2018 and 2025 GRI Bio, Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-12.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-10.0M.

Borrowings stand at $0, cash from operations was $-10.0M in the latest year, positive in 0 of the last 8.

Return on equity has averaged 18.0% over five years, and was -200.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, -94.3% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

GRI Bio, Inc. (GRI) — frequently asked questions